共 63 条
- [6] Palliative care: needs of advanced breast cancer patients [J]. BREAST CANCER-TARGETS AND THERAPY, 2018, 10 : 231 - 243
- [9] Final results from IMPROVE: a randomized, controlled, open-label, two-arm, cross-over phase IV study to determine patients' preference for everolimus in combination with exemestane or capecitabine in combination with bevacizumab in advanced HR-positive, HER2-negative breast cancer [J]. BMC CANCER, 2020, 20 (01)